Clinical Applications of Extracellular Vesicles in the Diagnosis and Treatment of Traumatic Brain Injury
Open accessThe DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
Extracellular vesicles (EVs) have emerged as key mediators of cell-cell communication during homeostasis and in pathology. Central nervous system (CNS)-derived EVs contain cell type-specific surface markers and intralumenal protein, RNA, DNA, and metabolite cargo that can be used to assess the biochemical and molecular state of neurons and glia during neurological injury and disease. The development of EV isolation strategies coupled with analysis of multi-plexed biomarker and clinical data have the potential to improve our ability to classify and treat traumatic brain injury (TBI) and resulting sequelae. Additionally, their ability to cross the blood-brain barrier (BBB) has implications for both EV-based diagnostic strategies and for potential EV-based therapeutics. In the present review, we discuss encouraging data for EV-based diagnostic, prognostic, and therapeutic strategies in the context of TBI monitoring and management.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Early Breast Cancer Trialists' Collaborative Group (EBCTCG) (2011) · The Lancet · doi:10.1016/s0140-6736(11)60993-8 · Cited by 3,075
Development, maintenance and disruption of the blood-brain barrier
Obermeier, B., Daneman, R., & Ransohoff, R. M. (2013) · Nature Medicine · doi:10.1038/nm.3407 · Cited by 2,452 · cited 3×
“139 BBB dysfunction in combination with the inflammation associated with TBI promotes migration of peripheral immune cells across the BBB. 140 The ability of naive macrophages able to cross the BBB through diapedesis requires the use of certain proteins such as lymphocyte function-associated…”
InfluentialChronic traumatic encephalopathy in athletes: Progressive tauopathy after repetitive head injury
McKee, A. C., Cantu, R. C., Nowinski, C. J., Hedley-Whyte, E. T., Gavett, B. E., Budson, A. E., Santini, V. E., Lee, H.-S., Kubilus, C. A., & Stern, R. A. (2009) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181a9d503 · Cited by 2,295 · cited 1×
“from other neurodegenerative conditions such as Alzheimer’s disease (AD).(87) Elevations in plasma and CSF levels of tau occur acutely after TBI,(88) but although plasma and CSF proteins have not served as adequate biomarkers of CTE,(89,90) many believe EVassociated proteins may provide a more accurate assessment of n…”
Drug Transport across the Blood–Brain Barrier
Pardridge, W. M. (2012) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2012.126 · Cited by 1,994
Pathophysiology of traumatic brain injury
Werner, C., & Engelhard, K. (2007) · British Journal of Anaesthesia · doi:10.1093/bja/aem131 · Cited by 1,712
Current and future perspectives of liquid biopsies in genomics-driven oncology
Heitzer, E., Haque, I. S., Roberts, C. E. S., & Speicher, M. R. (2019) · Nature Reviews Genetics · doi:10.1038/s41576-018-0071-5 · Cited by 1,557
Carroll, L., Cassidy, J. D., Peloso, P., Borg, J., von Holst, H., Holm, L., Paniak, C., & Pépin, M. (2004) · Journal of Rehabilitation Medicine · doi:10.1080/16501960410023859 · Cited by 1,326
Classification of traumatic brain injury for targeted therapies
Saatman, K. E., Duhaime, A.-C., Bullock, R., Maas, A. I. R., Valadka, A., & Manley, G. T. (2008) · Journal of Neurotrauma · doi:10.1089/neu.2008.0586 · Cited by 1,141
Zhang, Y., Chopp, M., Meng, Y., Katakowski, M., Xin, H., Mahmood, A., & Xiong, Y. (2015) · Journal of neurosurgery · doi:10.3171/2014.11.jns14770 · Cited by 737
Neurodegenerative causes of death among retired National Football League players
Lehman, E. J., Hein, M. J., Baron, S. L., & Gersic, C. M. (2012) · Neurology · doi:10.1212/wnl.0b013e31826daf50 · Cited by 638
Macrophage exosomes as natural nanocarriers for protein delivery to inflamed brain
Yuan, D., Zhao, Y., Banks, W. A., Bullock, K. M., Haney, M., Batrakova, E., & Kabanov, A. V. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.07.011 · Cited by 607 · cited 2×
“Other studies utilize EVs’ ability to cross the BBB to develop EV-based nanocarrier systems that deliver anti-inflammatory or neurotrophic factors into the inflamed CNS to treat neurodegenerative disease.(20,21)”
Horizontal transfer of oncogenes by uptake of apoptotic bodies
Bergsmedh, A., Szeles, A., Henriksson, M., Bratt, A., Folkman, M. J., Spetz, A.-L., & Holmgren, L. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.101129998 · Cited by 550
Elucidation of Exosome Migration Across the Blood–Brain Barrier Model In Vitro
Chen, C. C., Liu, L., Ma, F., Wong, C. W., Guo, X. E., Chacko, J. V., Farhoodi, H. P., Zhang, S. X., Zimak, J., Ségaliny, A., et al. (2016) · Cellular and Molecular Bioengineering · doi:10.1007/s12195-016-0458-3 · Cited by 537 · cited 3×
“83 EVs cross the BBB into peripheral circulation and have been isolated from nearly all bodily fluids including blood and CSF, 11,84 allowing for non-invasive assessment of the state of the injured and recovering CNS.”
Diagnosis, prognosis, and clinical management of mild traumatic brain injury
Levin, H. S., & Diaz-Arrastia, R. R. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00002-2 · Cited by 535 · cited 1×
“), functional outcomes such as the Glasgow Coma Scale (GCS), or by structural damage indicated by imaging techniques.(51) The”
Alzheimer’s disease pathology propagation by exosomes containing toxic amyloid-beta oligomers
Sardar Sinha, M., Ansell-Schultz, A., Civitelli, L., Hildesjö, C., Larsson, M., Lannfelt, L., Ingelsson, M., & Hallbeck, M. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1868-1 · Cited by 527
Neuroimaging after mild traumatic brain injury: review and meta-analysis
Eierud, C., Craddock, R. C., Fletcher, S., Aulakh, M., King-Casas, B., Kuehl, D., & LaConte, S. M. (2014) · NeuroImage: Clinical · doi:10.1016/j.nicl.2013.12.009 · Cited by 524 · cited 1×
“58 As an alternative to imaging and behavioral diagnostics, liquid biopsy is minimally invasive and can provide an accessible metric for the biochemical and molecular changes occurring in neurons and glia throughout the course of TBI.”
The pathophysiology of traumatic brain injury at a glance
Prins, M., Greco, T., Alexander, D., & Giza, C. C. (2013) · Disease Models & Mechanisms · doi:10.1242/dmm.011585 · Cited by 426
Dickens, A. M., Tovar-y-Romo, L. B., Yoo, S.-W., Trout, A. L., Bae, M., Kanmogne, M., Megra, B., Williams, D. W., Witwer, K. W., Gacias, M., et al. (2017) · Science Signaling · doi:10.1126/scisignal.aai7696 · Cited by 285
Traumatic brain injury and the risk of dementia diagnosis: a nationwide cohort study
Nordström, A., & Nordström, P. (2018) · PLOS Medicine · doi:10.1371/journal.pmed.1002496 · Cited by 254
Combining Machine Learning and Nanofluidic Technology To Diagnose Pancreatic Cancer Using Exosomes
Ko, J., Bhagwat, N., Yee, S. S., Ortiz, N., Sahmoud, A., Black, T., Aiello, N. M., McKenzie, L., O’Hara, M., Redlinger, C., et al. (2017) · ACS Nano · doi:10.1021/acsnano.7b05503 · Cited by 249
Self-citationExosome‐mediated inflammasome signaling after central nervous system injury
de Rivero Vaccari, J. P., Brand, F., Adamczak, S., Lee, S. W., Perez‐Barcena, J., Wang, M. Y., Bullock, M. R., Dietrich, W. D., & Keane, R. W. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13036 · Cited by 240
Emerging potential of exosomes for treatment of traumatic brain injury
Xiong, Y., Mahmood, A., & Chopp, M. (2017) · Neural Regeneration Research · doi:10.4103/1673-5374.198966 · Cited by 165 · cited 1×
“15,16,136,137 Administration of MSC-derived EVs promotes recovery following TBI through a combination of mechanisms.”
Stern, R. A., Tripodis, Y., Baugh, C. M., Fritts, N. G., Martin, B. M., Chaisson, C., Cantu, R. C., Joyce, J. A., Shah, S., Ikezu, T., et al. (2016) · Journal of Alzheimer’s Disease · doi:10.3233/jad-151028 · Cited by 155
Tau biology, tauopathy, traumatic brain injury, and diagnostic challenges
Castellani, R. J., & Perry, G. (2019) · Journal of Alzheimer’s Disease · doi:10.3233/jad-180721 · Cited by 110
Chen, C., Zong, S., Liu, Y., Wang, Z., Zhang, Y., Chen, B., & Cui, Y. (2019) · Small · doi:10.1002/smll.201901014 · Cited by 107
Strathmann, F. G., Schulte, S., Goerl, K., & Petron, D. J. (2014) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2014.01.028 · Cited by 98 · cited 1×
“60,61 For example, glial fibrillary acidic protein (GFAP), an intermediate filament protein expressed in astrocytes, and ubiquitin c-terminal hydrolase L1 (UCHL1), a neuronal cytosolic protein, successfully identify injury severity in acute TBI.”
Kenney, K., Qu, B.-X., Lai, C., Devoto, C., Motamedi, V., Walker, W. C., Levin, H. S., Nolen, T., Wilde, E. A., Diaz-Arrastia, R., et al. (2018) · Brain Injury · doi:10.1080/02699052.2018.1483530 · Cited by 94
Ko, J., Hemphill, M., Yang, Z., Sewell, E., Na, Y. J., Sandsmark, D. K., Haber, M., Fisher, S. A., Torre, E. A., Svane, K. C., et al. (2018) · Lab on a Chip · doi:10.1039/c8lc00672e · Cited by 89 · cited 1×
“In a study by Ko and colleagues, the investigators demonstrated the potential diagnostic utility of machine learning analysis of brain-derived EVs isolated with a microfluidic platform.(115) Brain-derived EVs were isolated based on their expression of GluR2, an a-amino-3hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA…”
Self-citationHepatic Nuclear Factor κB Regulates Neutrophil Recruitment to the Injured Brain
Campbell, S. J., Anthony, D. C., Oakley, F., Carlsen, H., Elsharkawy, A. M., Blomhoff, R., & Mann, D. A. (2008) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181654957 · Cited by 67
Extracellular vesicles: pathogenetic, diagnostic and therapeutic value in traumatic brain injury
Mondello, S., Thelin, E. P., Shaw, G., Salzet, M., Visalli, C., Cizkova, D., Kobeissy, F., & Buki, A. (2018) · Expert Review of Proteomics · doi:10.1080/14789450.2018.1464914 · Cited by 53
Combination therapies for traumatic brain injury: prospective considerations
Margulies, S. S., & Hicks, R. (2009) · Journal of Neurotrauma · doi:10.1089/neu.2008-0794 · Cited by 22
Cited by
Filannino, F. M., Panaro, M. A., Benameur, T., Pizzolorusso, I., & Porro, C. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25031629 · Cited by 60
Yarahmadi, A., Dorri Giv, M., Hosseininejad, R., Rezaie, A., Mohammadi, N., Afkhami, H., & Farokhi, A. (2025) · Frontiers in Neurology · doi:10.3389/fneur.2025.1472679 · Cited by 21
Clinical Theragnostic Signature of Extracellular Vesicles in Traumatic Brain Injury (TBI)
Dey, A., Ghosh, S., Bhuniya, T., Koley, M., Bera, A., Guha, S., Chakraborty, K., Muthu, S., Gorai, S., Vorn, R., et al. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00386 · Cited by 16
Metadata
- Authors
- Beard, K., Meaney, D. F., & Issadore, D.
- Venue
- Journal of Neurotrauma
- Publisher
- SAGE Publications
- Published
- 2020-10-01
- Volume
- 37
- Issue
- 19
- Pages
- 2045-2056
- ISSN
- 0897-7151 (ISSN-L)
- 1557-9042
- OpenAlex
- W3017334426
- Cited by
- 44
- References
- 31
- FWCI
- 1.66
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.